Genomics Market Report by Component (Products, Services), Application (Functional Genomics, Epigenomics, Biomarkers Discovery, Pathway Analysis, and Others), Technology (Sequencing, Microarray, Polymerase Chain Reaction, Nucleic Acid Extraction and Purification, and Others), End-User (Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Region 2024-2032
The global genomics market size reached US$ 33.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 107.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.3% during 2024-2032. The market is experiencing steady growth driven by the escalating government and private funding for genomics research across the globe, the rising application of genomics in drug discovery and development, and rising awareness of the potential benefits of genomic insights in improving health outcomes.
Genomics Market Analysis:
Technological innovations in sequencing technologies
According to the genomics market analysis, the fast pace of innovative advancements, especially in next-generation sequencing (NGS) and CRISPR-Cas9 genome altering innovations, serves as an essential driver for the genomics showcase. These headways have revolutionized hereditary investigation by essentially diminishing costs, expanding speed, and moving forward precision, subsequently making genomic sequencing more available and appropriate over a wide extend of businesses. Advancements in NGS innovations have empowered analysts to arrange DNA and RNA much more rapidly and cheaply than the already utilized Sanger sequencing, and as a result, have quickened the pace of genomics. This mechanical advance is increasing personalized medication, agrarian genomics, and microbial genomics, among others, catalyzing advanced ventures and intrigue within the field.
Growing demand for personalized medicine
Another important driver of the market is the rising across the globe need for personalized medicine, which customizes medical care according to each patient's unique characteristics. Customized medical treatment depends greatly on genetic data to inform the creation of specific therapies tailored to an individual's genetic composition, moving away from the generalized approach of traditional medicine to more accurate and efficient treatments. This also facilitates enhanced awareness among consumers that helps them find an answer for the “what is the genomics market?” question. Along with this, the increasing need is fueled by the expanding recognition and knowledge of the genetic causes of diseases, the increasing frequency of genetic conditions, and the limitations of conventional therapies for various illnesses. Using genomics in personalized medicine aims to enhance patient results and provides a cost-effective healthcare approach by prioritizing prevention and accurate treatment, which drives more investments and research in genomics.
Expansion in clinical applications and diagnostics
The market is also growing due to genomics technologies being utilized more for clinical applications and diagnostics, such as identifying genetic disorders, cancer screening, and monitoring infectious diseases. Improved understanding of the genetic basis of diseases has allowed for the incorporation of genomics into clinical care, resulting in the creation of novel diagnostic tools and genetic tests that can anticipate an individual's risk for specific conditions, guide treatment choices, and track disease advancement. A question arises, what is the demand for genomics, particularly in the field of clinical applications and diagnostics? Advancements in genomics technologies are anticipated to keep driving demand in this field, expanding their potential in diagnostics such as liquid biopsies and NIPT, highlighting the critical role genomics plays in revolutionizing healthcare and diagnostics.
Genomics Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on component, application, technology, and end-user.
Breakup by Component:
The report has provided a detailed breakup and analysis of the market based on the component. This includes products (instruments and software, consumables and reagents), services (core genomics services, NGS-based services, biomarker translation services, computational services, and others). According to the report, consumables and reagents represented the largest segment.
The consumables and reagents sector dominates the market due to their essential role in a variety of genomic procedures including DNA sequencing, gene editing, and sample preparation. With the increased use of genomics in sectors such as healthcare, agriculture, and biotechnology, there is a rising need for specific consumables and reagents, leading manufacturers to enhance and extend their product range. This is promoting the development of the consumables industry, emphasizing its crucial role in driving and applying genomics technologies, making a substantial contribution to the market's overall growth. Moreover, the strong demand for these products, which are essential for ensuring the accuracy and reliability of genomic analyses in research and clinical diagnostics, further solidifies the dominance of this industry sector.
Breakup by Application:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes functional genomics, epigenomics, biomarkers discovery, pathway analysis, and others. According to the report, functional genomics accounted for the largest market share.
Functional genomics, which focuses on gene functions and interactions, has become the dominant area in the market, showcasing its crucial importance in comprehending intricate biological processes and disease mechanisms. Utilizing high-throughput technologies including RNA sequencing and CRISPR-Cas9 in functional genomics enables in-depth study of gene expression and regulation, leading to progress in biomedical research and healthcare. Moreover, the growing emphasis on exploring the functional characteristics of the genome, along with the quick advancements in technology, positions functional genomics as a major force driving growth and innovation in the overall market.
Breakup by Technology:
The report has provided a detailed breakup and analysis of the market based on the technology. This includes sequencing, microarray, polymerase chain reaction, nucleic acid extraction and purification, and others. According to the report, sequencing represented the largest segment.
Sequencing technology is the main component of the market due to its crucial role in deciphering the genetic information found in DNA and RNA, making it the largest technological segment. The critical insights provided by sequencing drive this prominence in personalized medicine, genetic research, and diagnostic applications by uncovering genetic variations and mutations. Furthermore, the rise of NGS technologies is changing this field by offering unparalleled speed, accuracy, and cost-efficiency compared to traditional techniques. NGS enables a detailed analysis of genomes, exomes, and transcriptomes, allowing for progress in comprehending complex diseases, evolutionary biology, and microbial genomics.
Breakup by End-User:
A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes research centers, hospitals and clinics, pharmaceutical and, biotechnology companies, and others. According to the report, pharmaceutical and, biotechnology companies accounted for the largest market share.
Pharmaceutical and biotechnology companies are playing a major role in the market, emphasizing their significance in driving drug development and personalized medicine forward. These areas apply genomic data to identify novel targets for drugs, understand the genetic origins of diseases, and develop tailored treatments using individuals' genetic data. For instance, Illumina Inc., a top company in DNA sequencing and array-based technologies worldwide, partnered with Nashville Biosciences, LLC, a prominent clinical and genomic data company that is a subsidiary of Vanderbilt University Medical Center (VUMC), to reveal the five original members of the Alliance for Genomic Discovery (AGD). The extended agreement aims to quicken the treatment development process by conducting thorough genomics research and establishing a high-quality clinical genomics database. AbbVie, Amgen, AstraZeneca, Bayer, and Merck will pool their resources to fund the sequencing of 250,000 samples and can use the data for developing drugs and improving therapies.
Breakup by Region:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for genomics.
North America holds the largest market share due to its advanced healthcare system, significant investment in research and development, and the presence of top pharmaceutical and biotechnology companies. Additionally, the region's advanced technology in genomics and bioinformatics, along with these factors, is fostering a favorable environment for the development and advancement of the genomics field. North America's strong position in the global market is supported by the close collaboration between academic and research institutions with the industry, leading to innovation and setting trends that impact global genomics practices and policies.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the genomics industry include
Major players in the industry are involved in various strategic activities to uphold and strengthen their market presence. These businesses are making significant investments in research and development to launch new genomic technologies, services, and solutions that cater to their customers' changing needs. Working together, forming partnerships, and making acquisitions are important strategies that enable them to enhance their technological capabilities, enter new markets, and gain new genomic applications and intellectual property. Additionally, these top companies are focusing on improving their bioinformatics systems to manage and analyze the large amounts of data generated from genomic sequencing. This enables full solutions that help translate genomic findings into progress in clinical and agricultural sectors.
Genomics Market News:
1. What was the size of the global genomics market in 2023?
2. What is the expected growth rate of the global genomics market during 2024-2032?
3. What are the key factors driving the global genomics market?
4. What has been the impact of COVID-19 on the global genomics market?
5. What is the breakup of the global genomics market based on the component?
6. What is the breakup of the global genomics market based on the application?
7. What is the breakup of the global genomics market based on the technology?
8. What is the breakup of the global genomics market based on the end-user?
9. What are the key regions in the global genomics market?
10. Who are the key players/companies in the global genomics market?
Genomics Market Analysis:
- Major Market Drivers: The genomics market growth is driven by advancements in genetic sequencing technologies and an increasing interest in personalized medicine. Investments in R&D are pivotal, pushing the genomics market value upwards.
- Key Market Trends: Artificial intelligence (AI) and machine learning (ML) integration in genomics refer to the key genomics market trends, enhancing genomics market research capabilities. This trend aids in refining predictive modeling, leading to precise genomics market forecasts. The adoption of CRISPR gene editing technology highlights a significant shift in therapeutic applications, directly influencing genomics market demand.
- Geographical Trends: North America dominates in terms of genomics market revenue, due to its advanced healthcare infrastructure and a strong focus on research and innovation. The Asia-Pacific region shows the fastest genomics market growth rate, propelled by increasing government initiatives and a burgeoning focus on genomics research. This expansion offers a diverse genomics market overview, signaling varied growth prospects across different regions.
- Competitive Landscape: Notable market players in the genomics sector include Illumina, Inc., Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Oxford Nanopore Technologies, and CRISPR Therapeutics, among others. These entities are crucial in determining the genomics market outlook, with their competitive strategies and innovations significantly contributing to the market revenue.
- Challenges and Opportunities: Ethical concerns related to genetic data and the high costs associated with genomic sequencing pose challenges in the genomics market. Yet, these challenges also unveil opportunities for innovation to meet the increasing genomics market demand. Developing cost-effective sequencing methods and establishing ethical guidelines could further bolster the genomics market value and facilitate genomics market growth.
Technological innovations in sequencing technologies
According to the genomics market analysis, the fast pace of innovative advancements, especially in next-generation sequencing (NGS) and CRISPR-Cas9 genome altering innovations, serves as an essential driver for the genomics showcase. These headways have revolutionized hereditary investigation by essentially diminishing costs, expanding speed, and moving forward precision, subsequently making genomic sequencing more available and appropriate over a wide extend of businesses. Advancements in NGS innovations have empowered analysts to arrange DNA and RNA much more rapidly and cheaply than the already utilized Sanger sequencing, and as a result, have quickened the pace of genomics. This mechanical advance is increasing personalized medication, agrarian genomics, and microbial genomics, among others, catalyzing advanced ventures and intrigue within the field.
Growing demand for personalized medicine
Another important driver of the market is the rising across the globe need for personalized medicine, which customizes medical care according to each patient's unique characteristics. Customized medical treatment depends greatly on genetic data to inform the creation of specific therapies tailored to an individual's genetic composition, moving away from the generalized approach of traditional medicine to more accurate and efficient treatments. This also facilitates enhanced awareness among consumers that helps them find an answer for the “what is the genomics market?” question. Along with this, the increasing need is fueled by the expanding recognition and knowledge of the genetic causes of diseases, the increasing frequency of genetic conditions, and the limitations of conventional therapies for various illnesses. Using genomics in personalized medicine aims to enhance patient results and provides a cost-effective healthcare approach by prioritizing prevention and accurate treatment, which drives more investments and research in genomics.
Expansion in clinical applications and diagnostics
The market is also growing due to genomics technologies being utilized more for clinical applications and diagnostics, such as identifying genetic disorders, cancer screening, and monitoring infectious diseases. Improved understanding of the genetic basis of diseases has allowed for the incorporation of genomics into clinical care, resulting in the creation of novel diagnostic tools and genetic tests that can anticipate an individual's risk for specific conditions, guide treatment choices, and track disease advancement. A question arises, what is the demand for genomics, particularly in the field of clinical applications and diagnostics? Advancements in genomics technologies are anticipated to keep driving demand in this field, expanding their potential in diagnostics such as liquid biopsies and NIPT, highlighting the critical role genomics plays in revolutionizing healthcare and diagnostics.
Genomics Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on component, application, technology, and end-user.
Breakup by Component:
- Products
- Instruments and Software
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others
The report has provided a detailed breakup and analysis of the market based on the component. This includes products (instruments and software, consumables and reagents), services (core genomics services, NGS-based services, biomarker translation services, computational services, and others). According to the report, consumables and reagents represented the largest segment.
The consumables and reagents sector dominates the market due to their essential role in a variety of genomic procedures including DNA sequencing, gene editing, and sample preparation. With the increased use of genomics in sectors such as healthcare, agriculture, and biotechnology, there is a rising need for specific consumables and reagents, leading manufacturers to enhance and extend their product range. This is promoting the development of the consumables industry, emphasizing its crucial role in driving and applying genomics technologies, making a substantial contribution to the market's overall growth. Moreover, the strong demand for these products, which are essential for ensuring the accuracy and reliability of genomic analyses in research and clinical diagnostics, further solidifies the dominance of this industry sector.
Breakup by Application:
- Functional Genomics
- Epigenomics
- Biomarkers Discovery
- Pathway Analysis
- Others
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes functional genomics, epigenomics, biomarkers discovery, pathway analysis, and others. According to the report, functional genomics accounted for the largest market share.
Functional genomics, which focuses on gene functions and interactions, has become the dominant area in the market, showcasing its crucial importance in comprehending intricate biological processes and disease mechanisms. Utilizing high-throughput technologies including RNA sequencing and CRISPR-Cas9 in functional genomics enables in-depth study of gene expression and regulation, leading to progress in biomedical research and healthcare. Moreover, the growing emphasis on exploring the functional characteristics of the genome, along with the quick advancements in technology, positions functional genomics as a major force driving growth and innovation in the overall market.
Breakup by Technology:
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
The report has provided a detailed breakup and analysis of the market based on the technology. This includes sequencing, microarray, polymerase chain reaction, nucleic acid extraction and purification, and others. According to the report, sequencing represented the largest segment.
Sequencing technology is the main component of the market due to its crucial role in deciphering the genetic information found in DNA and RNA, making it the largest technological segment. The critical insights provided by sequencing drive this prominence in personalized medicine, genetic research, and diagnostic applications by uncovering genetic variations and mutations. Furthermore, the rise of NGS technologies is changing this field by offering unparalleled speed, accuracy, and cost-efficiency compared to traditional techniques. NGS enables a detailed analysis of genomes, exomes, and transcriptomes, allowing for progress in comprehending complex diseases, evolutionary biology, and microbial genomics.
Breakup by End-User:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes research centers, hospitals and clinics, pharmaceutical and, biotechnology companies, and others. According to the report, pharmaceutical and, biotechnology companies accounted for the largest market share.
Pharmaceutical and biotechnology companies are playing a major role in the market, emphasizing their significance in driving drug development and personalized medicine forward. These areas apply genomic data to identify novel targets for drugs, understand the genetic origins of diseases, and develop tailored treatments using individuals' genetic data. For instance, Illumina Inc., a top company in DNA sequencing and array-based technologies worldwide, partnered with Nashville Biosciences, LLC, a prominent clinical and genomic data company that is a subsidiary of Vanderbilt University Medical Center (VUMC), to reveal the five original members of the Alliance for Genomic Discovery (AGD). The extended agreement aims to quicken the treatment development process by conducting thorough genomics research and establishing a high-quality clinical genomics database. AbbVie, Amgen, AstraZeneca, Bayer, and Merck will pool their resources to fund the sequencing of 250,000 samples and can use the data for developing drugs and improving therapies.
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for genomics.
North America holds the largest market share due to its advanced healthcare system, significant investment in research and development, and the presence of top pharmaceutical and biotechnology companies. Additionally, the region's advanced technology in genomics and bioinformatics, along with these factors, is fostering a favorable environment for the development and advancement of the genomics field. North America's strong position in the global market is supported by the close collaboration between academic and research institutions with the industry, leading to innovation and setting trends that impact global genomics practices and policies.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the genomics industry include
- 23andMe, Inc
- Agilent Technologies, Inc.
- Bayer AG
- BGI Group
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Illumina, Inc.
- Oxford Nanopore Technologies
- PerkinElmer, Inc.
- Myriad Genetics, Inc.
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
Major players in the industry are involved in various strategic activities to uphold and strengthen their market presence. These businesses are making significant investments in research and development to launch new genomic technologies, services, and solutions that cater to their customers' changing needs. Working together, forming partnerships, and making acquisitions are important strategies that enable them to enhance their technological capabilities, enter new markets, and gain new genomic applications and intellectual property. Additionally, these top companies are focusing on improving their bioinformatics systems to manage and analyze the large amounts of data generated from genomic sequencing. This enables full solutions that help translate genomic findings into progress in clinical and agricultural sectors.
Genomics Market News:
- October 30, 2023: 23andMe, Inc announced a fresh, non-exclusive data agreement with GSK plc that expands their partnership and grants GSK the ability to perform drug target discovery and other studies using the 23andMe database, the largest collection of genetic and phenotypic information from consenting participants that can be contacted again. According to a revision of their Collaboration Agreement, 23andMe is set to receive a $20 million initial payment for a one-year, non-exclusive data license.
- March 14, 2023: Agilent Technologies, Inc. declared a collaboration with Agilent to provide a complete cancer analysis solution. The partnership will see the integration of the SOPHiA DDM Platform with Agilent's new Research Use Only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit. This will allow clinical researchers to precisely detect several biomarkers, reducing the chance of overlooking crucial information in cancer samples.
1. What was the size of the global genomics market in 2023?
2. What is the expected growth rate of the global genomics market during 2024-2032?
3. What are the key factors driving the global genomics market?
4. What has been the impact of COVID-19 on the global genomics market?
5. What is the breakup of the global genomics market based on the component?
6. What is the breakup of the global genomics market based on the application?
7. What is the breakup of the global genomics market based on the technology?
8. What is the breakup of the global genomics market based on the end-user?
9. What are the key regions in the global genomics market?
10. Who are the key players/companies in the global genomics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL GENOMICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY COMPONENT
6.1 Products
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Instruments and Software
6.1.2.2 Consumables and Reagents
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Core Genomics Services
6.2.2.2 NGS-Based Services
6.2.2.3 Biomarker Translation Services
6.2.2.4 Computational Services
6.2.2.5 Others
6.2.3 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Functional Genomics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epigenomics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biomarkers Discovery
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pathway Analysis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY TECHNOLOGY
8.1 Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Microarray
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Polymerase Chain Reaction
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nucleic Acid Extraction and Purification
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END-USER
9.1 Research Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE INDICATORS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 23andMe, Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Agilent Technologies, Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer Aktiengesellschaft
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 BGI Genomics Co. Ltd.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Bio-RAD Laboratories Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Danaher Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Illumina Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Nanopore Technologies
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 PerkinElmer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Roche Holding AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL GENOMICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY COMPONENT
6.1 Products
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Instruments and Software
6.1.2.2 Consumables and Reagents
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Core Genomics Services
6.2.2.2 NGS-Based Services
6.2.2.3 Biomarker Translation Services
6.2.2.4 Computational Services
6.2.2.5 Others
6.2.3 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Functional Genomics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epigenomics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biomarkers Discovery
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pathway Analysis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY TECHNOLOGY
8.1 Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Microarray
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Polymerase Chain Reaction
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nucleic Acid Extraction and Purification
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END-USER
9.1 Research Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE INDICATORS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 23andMe, Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Agilent Technologies, Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer Aktiengesellschaft
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 BGI Genomics Co. Ltd.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Bio-RAD Laboratories Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Danaher Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Illumina Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Nanopore Technologies
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 PerkinElmer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Roche Holding AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Genomics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Genomics Market: Competitive Structure
Table 8: Global: Genomics Market: Key Players
Table 1: Global: Genomics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Genomics Market: Competitive Structure
Table 8: Global: Genomics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Genomics Market: Major Drivers and Challenges
Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Genomics Market: Breakup by Component (in %), 2023
Figure 4: Global: Genomics Market: Breakup by Application (in %), 2023
Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2023
Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2023
Figure 7: Global: Genomics Market: Breakup by Region (in %), 2023
Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: China: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: India: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: France: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Global: Genomics Industry: SWOT Analysis
Figure 90: Global: Genomics Industry: Value Chain Analysis
Figure 91: Global: Genomics Industry: Porter’s Five Forces Analysis
Figure 1: Global: Genomics Market: Major Drivers and Challenges
Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Genomics Market: Breakup by Component (in %), 2023
Figure 4: Global: Genomics Market: Breakup by Application (in %), 2023
Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2023
Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2023
Figure 7: Global: Genomics Market: Breakup by Region (in %), 2023
Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: China: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: India: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: France: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Global: Genomics Industry: SWOT Analysis
Figure 90: Global: Genomics Industry: Value Chain Analysis
Figure 91: Global: Genomics Industry: Porter’s Five Forces Analysis
